Entries by CAPTIS

ViewRay wins FDA nod for MRIdian system soft tissue visualization capabilities

02/22/2019 /0 Comments/in , , , , /by

ViewRay (NSDQ:VRAY)  said yesterday that it won FDA 510(k) clearance to offer soft tissue visualization capabilities with its MRIdian system. The newly cleared features include expanded high-definition visualization and contrast between tissues, diffusion weighted imaging for improved distinguishing between normal and tumor tissues and more detailed, brighter and faster anatomical planar imaging, the Cleveland-based company said. […]

Boston Scientific prices $4.3m senior notes offering

02/22/2019 /0 Comments/in , , , , /by

Boston Scientific (NYSE:BSX) yesterday priced a public offering of senior notes worth approximately $4.3 billion. The Marlborough, Mass.-based company said that it plans to offer $850 million in 3.45% notes due 2024, $850 million in 3.75% notes due 2026, $850 million in 4% notes due 2029, $750 million in 4.55% notes due 2039 and $1 billion […]

Abbott touts real-world data for FreeStyle Libre glucose monitor

02/22/2019 /0 Comments/in , , , , , /by

Abbott (NYSE:ABT) presented real-world data this week showing that use of its FreeStyle Libre glucose monitoring system reduced prolonged hypoglycemia and helped users achieve better glucose control. At the 12th Advanced Technologies & Treatments for Diabetes meeting in Berlin, the company showcased a real-world evidence data set that included roughly 500,000 FreeStyle Libre system users. Get […]

Mylan launches generic sublingual film for opioid dependence

02/22/2019 /0 Comments/in , , , , , , , /by

Mylan (NSDQ:MYL) said today that it launched its buprenorphine and naloxone sublingual film as a generic of Indivior‘s (LON:INDV) Suboxone sublingual film. The product is indicated for the treatment of opioid dependence. The therapy should be used alongside counseling and psychosocial support for people living with opioid dependence, according to Mylan. Get the full story at our […]

Propeller Health study suggests 84% of asthma inhaler use performed incorrectly

02/21/2019 /0 Comments/in , , , , /by

ResMed (NYSE:RMD) subsidiary Propeller Health today released results from a new study exploring real-world use of rescue or controller inhalers that indicated that the majority of users did not use their inhalers properly. Results from the research were published in The Journal of Allergy and Clinical Immunology: In Practice, the Madison, Wisc.-based company said. Read the whole story on […]

LivaNova wins Japanese reimbursement for Perceval aortic valve

02/21/2019 /0 Comments/in , , , /by

LivaNova (NSDQ:LIVN) said today that it won national reimbursement through Japan’s Ministry of Health, Labour and Welfare for its Perceval sutureless aortic heart valve intended to treat aortic valve disease. The London-based company said that the elastic Perceval valve’s sutureless design allows it to achieve optimal effective orifice area for improved hemodynamics. The company said that […]